A Phase 2 Study Comparing Treatment With LEO 90100 With Calcipotriol Plus Betamethasone Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Trial Profile

A Phase 2 Study Comparing Treatment With LEO 90100 With Calcipotriol Plus Betamethasone Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone/calcipotriol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 07 Mar 2016 Primary endpoint has been met. (Investigators global assessment of disease severity), as reported by Leo-pharma media release.
    • 07 Mar 2016 Results published in Leo-pharma media release.
    • 04 Sep 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top